conv.

All stories
Active · 22h

EXO1 is a promising target to treat BRCA1-deficient breast cancer. Sebastian Pomplun and Sylvie Noordermeer have just received €1.18 Mio by…

latest 22h ago3 items1 engagement Mastodon

Conversation activity · last 23 hours presspostscomments the crowd ↓

Peak 3 items in one 30m at Yesterday, 4 AM; 3 items over 23 hours (3 posts) Yesterday, 4:14 AM — no itemsYesterday, 4:44 AM — 3 items · 3 posts — Mastodon 3Yesterday, 5:14 AM — no itemsYesterday, 5:44 AM — no itemsYesterday, 6:14 AM — no itemsYesterday, 6:44 AM — no itemsYesterday, 7:14 AM — no itemsYesterday, 7:44 AM — no itemsYesterday, 8:14 AM — no itemsYesterday, 8:44 AM — no itemsYesterday, 9:14 AM — no itemsYesterday, 9:44 AM — no itemsYesterday, 10:14 AM — no itemsYesterday, 10:44 AM — no itemsYesterday, 11:14 AM — no itemsYesterday, 11:44 AM — no itemsYesterday, 12:14 PM — no itemsYesterday, 12:44 PM — no itemsYesterday, 1:14 PM — no itemsYesterday, 1:44 PM — no itemsYesterday, 2:14 PM — no itemsYesterday, 2:44 PM — no itemsYesterday, 3:14 PM — no itemsYesterday, 3:44 PM — no itemsYesterday, 4:14 PM — no itemsYesterday, 4:44 PM — no itemsYesterday, 5:14 PM — no itemsYesterday, 5:44 PM — no itemsYesterday, 6:14 PM — no itemsYesterday, 6:44 PM — no itemsYesterday, 7:14 PM — no itemsYesterday, 7:44 PM — no itemsYesterday, 8:14 PM — no itemsYesterday, 8:44 PM — no itemsYesterday, 9:14 PM — no itemsYesterday, 9:44 PM — no itemsYesterday, 10:14 PM — no itemsYesterday, 10:44 PM — no itemsYesterday, 11:14 PM — no itemsYesterday, 11:44 PM — no itemsToday, 12:14 AM — no itemsToday, 12:44 AM — no itemsToday, 1:14 AM — no itemsToday, 1:44 AM — no itemsToday, 2:14 AM — no itemsToday, 2:44 AM — no items 3 items · 4:44 AM
8 AM12 PM4 PM8 PMtodaynow · 3:14 AM
Every item, in order 3

Clustered from 3 items across 1 source. Not yet parsed — the coverage below is the raw record.

Social posts 1

The conversation unedited, verbatim

3 collected here from 1 site · 2 voices below over time ↑

  • Yesterday

  • How can a specific weakness of the tumor be targeted to treat cancer? For the case of BRCA1-deficient breast cancer, the groups of Sebastian Pomplun and Sylvie Noordermeer are now setting out to address this question by targeting EXO1. Read the full story: https://www. staff.universiteitleiden.nl/ne…

    LED3hub@mstdn.scienceMastodon · fosstodon.org22h ago1▲view on Mastodon ↗

  • EXO1 is a promising target to treat BRCA1-deficient breast cancer. Sebastian Pomplun and Sylvie Noordermeer have just received €1.18 Mio by the KWF to tackle this promising, but challenging target. Here, you can read an insightful explanation of their project: https://www. staff.universiteitleiden.nl/ne…

    Stephanhacker2@mstdn.scienceMastodon · toot.community22h agoview on Mastodon ↗